D M Heyes|D Dini|E R Smith - JoVE Visualize

Showing results (341-350 of 392) with videos related to

Pageof 40

Sort By:

Mutation Research|December 1, 1984

Sperm count, morphology and fluorescent body frequency in autopsy service workers exposed to formaldehydeJ B Ward, J A Hokanson, E R Smith, et al.

Scientific Reports|April 16, 2025

Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelinKatherine E R Smith, Jennifer R Ayers-Ringler, Jacob J Orme, et al.

Clinical Physiology (Oxford, England)|January 1, 1991

Left and right ventricular diastolic function during acute pericardial tamponadeO A Smiseth, M A Frais, M Junemann, et al.

AJNR. American Journal of Neuroradiology|February 12, 2011

Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patientsA I Alomari, G Chaudry, G Rodesch, et al.

Eating Disorders|February 1, 2018

Affective predictors of the severity and change in eating psychopathology in residential eating disorder treatment: The role of social anxietyKathryn E Smith, Tyler B Mason, Rachel C Leonard, et al.

Circulation|October 1, 1995

Spatial features in body-surface potential maps can identify patients with a history of sustained ventricular tachycardiaC L Hubley-Kozey, L B Mitchell, M J Gardner, et al.

Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1995

Measurement of intestinal vascular capacitance in dogs: an application of blood pool scintigraphyN W Scott-Douglas, D E Manyari, O A Smiseth, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998

ESA1 is a histone acetyltransferase that is essential for growth in yeastE R Smith, A Eisen, W Gu, et al.

Circulation|August 1, 1992

Electrocardiographic body surface mapping in patients with ventricular tachycardia. Assessment of utility in the identification of effective pharmacological therapyL B Mitchell, C L Hubley-Kozey, E R Smith, et al.

Natural Toxins|January 1, 1996

Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisinsR T Riley, E Wang, J J Schroeder, et al.

Pageof 40

Showing results (341-350 of 392) with videos related to

Sort By:

Pageof 40

Mutation Research|December 1, 1984

Sperm count, morphology and fluorescent body frequency in autopsy service workers exposed to formaldehydeJ B Ward, J A Hokanson, E R Smith, et al.

Scientific Reports|April 16, 2025

Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelinKatherine E R Smith, Jennifer R Ayers-Ringler, Jacob J Orme, et al.

Clinical Physiology (Oxford, England)|January 1, 1991

Left and right ventricular diastolic function during acute pericardial tamponadeO A Smiseth, M A Frais, M Junemann, et al.

AJNR. American Journal of Neuroradiology|February 12, 2011

Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patientsA I Alomari, G Chaudry, G Rodesch, et al.

Eating Disorders|February 1, 2018

Affective predictors of the severity and change in eating psychopathology in residential eating disorder treatment: The role of social anxietyKathryn E Smith, Tyler B Mason, Rachel C Leonard, et al.

Circulation|October 1, 1995

Spatial features in body-surface potential maps can identify patients with a history of sustained ventricular tachycardiaC L Hubley-Kozey, L B Mitchell, M J Gardner, et al.

Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1995

Measurement of intestinal vascular capacitance in dogs: an application of blood pool scintigraphyN W Scott-Douglas, D E Manyari, O A Smiseth, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998

ESA1 is a histone acetyltransferase that is essential for growth in yeastE R Smith, A Eisen, W Gu, et al.

Circulation|August 1, 1992

Electrocardiographic body surface mapping in patients with ventricular tachycardia. Assessment of utility in the identification of effective pharmacological therapyL B Mitchell, C L Hubley-Kozey, E R Smith, et al.

Natural Toxins|January 1, 1996

Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisinsR T Riley, E Wang, J J Schroeder, et al.

Pageof 40